Public Health | May 07, 2026
Experts call for easing access to 2mg and 4mg nicotine replacement therapies
With 267 million tobacco users, improving access to evidence-based cessation tools is seen as critical
With 267 million tobacco users, improving access to evidence-based cessation tools is seen as critical
The private funding rose 38% amid growing international collaborations and CDMO demand
Compared to a net loss of Rs 12 crore in FY25, the pharma major reported a consolidated turnaround in its financial performance
In Q4 FY26, the company reported revenue from operations of Rs 176.9 crore, marking a 23.6% year-on-year growth
Steady growth led by biologics and CRDMO business, EBITDA margin at 25% with continued investments in ADCs, peptides, and digital capabilities
Domestic sales increased 15.5%, supported by the relaunch of previously recalled products in the market
Multi-stakeholder initiative highlights inclusive sports pathways, honours neurodivergent athletes, and calls for systemic reforms
Stakeholders call for coordinated action on diagnostics, vaccines, and health system readiness as the monsoon season approaches
Policy symposium in Hyderabad focuses on life skills education and community?driven solutions
Medical experts point to a growing body of research linking energy drinks to liver injury
Subscribe To Our Newsletter & Stay Updated
